The most commonly prescribed medications for CAD were SGLT2ins (alone or in combination), while GLP-1 RAs (alone or in combination), DPP-4ins (alone or in combination), and the combination of SGLT2ins and GLP-1 RAs were less common and equally represented. This evidence concerns the gene GLP1R and coronary artery disorder.